Reynolds Cameron John 4
4 · VOLITIONRX LTD · Filed May 22, 2020
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Reynolds Cameron John
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2020-05-22$2.75/sh+4,000$11,000→ 1,126,273 total
Holdings
- 34,076(indirect: By Spouse)
Common Stock
- 1,007,718(indirect: Concord International, Inc.)
Common Stock
Footnotes (2)
- [F1]The shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on May 22, 2020. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriter.
- [F2]The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.